NCT06435624

Brief Summary

The goal of this clinical trial is to learn if intelligent rehabilitation robot training system combined with repetitive facilitative exercise (RFE) work to treat stroke in adults. The main questions it aims to answer are: Does drug intelligent rehabilitation robot training system combined with RFE improve the upper limb motor function of participants? Can the combination of intelligent rehabilitation robot training system and RFE achieve better effects? Researchers will compare 3 groups (RFE, intelligent rehabilitation robot training system under RFE, and conventional therapy) to see if intelligent rehabilitation robot training system and RFE works to treat stroke. Participants will: Receive treatment for 4 weeks Receive scale and instrument testing before and after treatment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 30, 2024

Completed
16 days until next milestone

Study Start

First participant enrolled

June 15, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
6 months until next milestone

Results Posted

Study results publicly available

March 5, 2025

Completed
Last Updated

March 5, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

May 21, 2024

Results QC Date

November 14, 2024

Last Update Submit

February 11, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

    The FMA-UE consists of 33 items across nine components, including reflex action, synergy, and coordination, with a maximum score of 66 points. Each items is scored from 0 (no ability) to 2 (full ability), with higher scores indicating better upper limb motor function.

    From enrollment to the end of treatment at 4 weeks

  • Active Participation Proportion

    Active Participation Proportion (APP) is measured using the benchmark evaluation system within the intelligent rehabilitation robot training system. The robotic arm's mechanical sensor continuously detects the force exerted by the patient during the test game and quantifies APP as the ratio of the patient's applied force to the total force required to complete the task (%). A higher APP indicates greater voluntary effort in movement execution. Since the test game difficulty is fixed, APP increases as the patient's motor ability improves.

    From enrollment to the end of treatment at 4 weeks

  • Trajectory Deviation

    Trajectory Deviation (TD) is assessed by comparing the actual motion trajectory with a predefined reference trajectory using the intelligent rehabilitation robot training system. TD is calculated as the mean Euclidean distance (in mm) between discrete points along the actual movement path and the nearest corresponding points on the reference trajectory. This metric provides a measure of point-specific accuracy and precision in following the ideal movement path, with smaller TD values indicating better trajectory control.

    From enrollment to the end of treatment at 4 weeks

  • Trajectory Tracking Error

    Description: Trajectory Tracking Error (TTE) quantifies the cumulative deviation between the actual movement path and the predefined reference trajectory. It is computed as the sum of absolute differences in trajectory length between the two paths (in mm). TTE reflects overall movement efficiency and smoothness, capturing the patient's ability to maintain an optimal movement path throughout the task. A lower TTE indicates better movement planning and motor control.

    From enrollment to the end of treatment at 4 weeks

Study Arms (3)

IRAT group

EXPERIMENTAL

The Intelligent robotic-assisted training (IRAT) group received a 30 minute RFE intervention and a 30 minute IRAT intervention.

Device: intelligent robotic-assisted trainingOther: repetitive facilitative exercise

RFE group

ACTIVE COMPARATOR

The Repetitive facilitative exercise (RFE) group received a 60 minute RFE intervention.

Other: repetitive facilitative exercise

CT group

ACTIVE COMPARATOR

The Conventional therapy (CT) group received a 60 minute conventional rehabilitation intervention.

Other: conventional therapy

Interventions

Using an intelligent robotic-assisted training (IRAT) system to simulate a real work environment, providing functional oriented treatment for stroke patients and improving upper limb motor function. The instrument used is the Burt upper limb robot training system produced by Estun Medical Co., Ltd.

IRAT group

Repetitive facilitative exercise (RFE) is a new technology that combines multiple sensory stimuli and achieves facilitation and reinforcement of the reconstruction of paralyzed neural pathways through repeated and extensive directional exercise.

IRAT groupRFE group

Basic training, including passive joint movement and activities of daily living exercise.

CT group

Eligibility Criteria

Age18 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients (18 to 74 years old) who suffered a first or second unilateral stroke
  • chronic stroke (over 6 months from the onset)
  • obvious upper limb movement disorders (FMA-UE scores from 25 to 42)
  • ability to understand and follow simple directions

You may not qualify if:

  • pregnant or lactating
  • upper extremity contracture, pain, or trauma
  • perceptual, apraxic, or cognitive deficits that lead to inability to follow verbal instructions
  • unable to maintain sitting posture
  • cerebellar lesion
  • clinically unstable medical disorders
  • inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing Mingzhou Rehabilitation Hospital

Nanjing, Jiangsu, 210046, China

Location

Related Publications (1)

  • Zhang JZ, Chen J, Liu XL, Yan LB, Xu SM. Effectiveness of intelligent robotic-assisted training system combined with repetitive facilitative exercise on upper limb motor function after stroke: a randomized controlled trial. BMC Sports Sci Med Rehabil. 2025 Jul 3;17(1):178. doi: 10.1186/s13102-025-01234-y.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Limitations and Caveats

The intervention period was relatively short and lacked long-term follow-up.

Results Point of Contact

Title
Jingzhi Zhang
Organization
Nanjing Mingzhou Rehabilitation Hospital

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
technician

Study Record Dates

First Submitted

May 21, 2024

First Posted

May 30, 2024

Study Start

June 15, 2024

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

March 5, 2025

Results First Posted

March 5, 2025

Record last verified: 2025-02

Locations